about
Suppression of nonhomologous end joining repair by overexpression of HMGA2Suppression of non-small cell lung tumor development by the let-7 microRNA familyBinding the mammalian high mobility group protein AT-hook 2 to AT-rich deoxyoligonucleotides: enthalpy-entropy compensation.Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasmsDerepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.Reversible block of mouse neural stem cell differentiation in the absence of dicer and microRNAs.3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice.A rapid and sensitive high-throughput screening method to identify compounds targeting protein-nucleic acids interactions.Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes.High mobility group proteins and their post-translational modifications.Gene therapy for hemoglobinopathies: progress and challenges.miRNA modulation of the cellular stress response.HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cellsHMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPPIsomerization kinetics of AT hook decapeptide solution structures.Insertional oncogenesis by non-acute retroviruses: implications for gene therapy.HMGA2 and high-grade serous ovarian carcinoma.Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.HMGA2 Expression in Renal Carcinoma and its Clinical SignificanceRKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN.Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.Dwarfism and Altered Craniofacial Development in Rabbits Is Caused by a 12.1 kb Deletion at the HMGA2 Locus.Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms.HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway
P2860
Q24338991-FE3FA75A-1F4C-4F12-852B-7EB6600055AAQ24651985-EC5937CD-8B09-4A35-ACCF-F586FFA58CAEQ30481431-768CA60F-C6BD-4C02-97DB-E738633E8A7AQ33573793-46A68C77-937B-41D9-892A-DBB249E94FBCQ33717478-8A73C834-3B3B-48BB-8C25-B31692D0E75CQ33734313-77A84F21-1254-4F31-9C9C-980265F4F306Q34208062-40396FDF-F8AF-43BF-AF8C-1322AE76BAC8Q35037403-388ABAA7-AE51-47B6-AC25-5B9CA717E669Q35562028-E6E2D44D-D06A-41A2-A685-0E9E23F3CF15Q35825994-DE87222F-2129-44E2-8680-D22043A6D654Q37015673-CA9A68E6-73CD-4932-B298-37A82AA95756Q37027448-8B13B60A-2D12-411C-9831-B4F7653ACC2EQ37137022-E0C34ADC-5A74-45BA-B125-E0EA3AD8F137Q37150773-BC30CD7E-1F7D-4BC7-9C76-A99E33B3E129Q37403864-EF8D97FA-AAAB-431B-A277-FB4BF555544DQ37585120-2319EF3D-2943-4695-A0A7-EA1936BE4134Q37604273-E8DD21A8-BE66-449B-A401-16857DA6B2CAQ37945223-A8788E9F-962F-4AE0-B5D0-872EB9515F24Q38107833-51045E07-5187-44BD-8FBC-6DC78F3C36C6Q38787288-FAE5DFEE-F75C-4E56-AE76-DBA0279BD959Q38790943-7E93C148-49F4-4CA6-814C-FE305DEB2564Q38837784-9D177E72-3CE6-412E-A2F3-46D0B61077C5Q38868171-4350F60A-F1CA-4259-A241-B4D213DEADE4Q38961655-A8C10502-CF06-4102-ABDB-08856F733FF4Q39539355-EAEC8588-8EFF-43F6-8879-DF6505755DA8Q42114395-4DC505B5-FCC2-4FFC-A49F-D9F5E1D8F4BCQ45874313-A023A796-232E-4B54-9235-2365B040B347Q46444733-D63FE910-21D4-488A-9F06-7B4A204CB06CQ47131773-DFFFFFFB-16CE-4FE6-9649-B1C94C0861CEQ47742839-CEE7BC07-C06A-414B-975B-BE2297EF237FQ48002616-26971A02-49D2-4D4A-878B-3D8CDD61277DQ49288145-AC17946B-76DD-446C-83AE-5D1F499D6E00Q55071119-69210520-FA1F-43C9-B7C9-3C9DC5C46526Q58733935-47C3D8C5-BEF4-432E-A4C4-430165398AF0
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oncogenic HMGA2: short or small?
@ast
Oncogenic HMGA2: short or small?
@en
type
label
Oncogenic HMGA2: short or small?
@ast
Oncogenic HMGA2: short or small?
@en
prefLabel
Oncogenic HMGA2: short or small?
@ast
Oncogenic HMGA2: short or small?
@en
P356
P1433
P1476
Oncogenic HMGA2: short or small?
@en
P2093
Andrew R J Young
P304
P356
10.1101/GAD.1554707
P577
2007-05-01T00:00:00Z